Caltrate Gummy Bites Interactions
There are 270 drugs known to interact with Caltrate Gummy Bites (calcium/vitamin d), along with 11 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 17 are major, 200 are moderate, and 53 are minor.
- View all 270 medications that may interact with Caltrate Gummy Bites
- View Caltrate Gummy Bites alcohol/food interactions (1)
- View Caltrate Gummy Bites disease interactions (11)
Most frequently checked interactions
View interaction reports for Caltrate Gummy Bites (calcium / vitamin d) and the medicines listed below.
- acetaminophen
- acyclovir
- Adderall (amphetamine / dextroamphetamine)
- atorvastatin
- biotin
- Colace (docusate)
- cyclobenzaprine
- Cymbalta (duloxetine)
- fluticasone nasal
- gabapentin
- hydrochlorothiazide
- levothyroxine
- lisinopril
- lorazepam
- losartan
- MiraLAX (polyethylene glycol 3350)
- Mucinex (guaifenesin)
- multivitamin
- Nexium (esomeprazole)
- omeprazole
- potassium chloride
- prednisone
- Restasis (cyclosporine ophthalmic)
- simvastatin
- Singulair (montelukast)
- Vitamin B12 (cyanocobalamin)
- Vitamin C (ascorbic acid)
- Vitamin D2 (ergocalciferol)
- Vitamin D3 (cholecalciferol)
- Vyvanse (lisdexamfetamine)
Caltrate Gummy Bites alcohol/food interactions
There is 1 alcohol/food interaction with Caltrate Gummy Bites (calcium / vitamin d).
Caltrate Gummy Bites disease interactions
There are 11 disease interactions with Caltrate Gummy Bites (calcium / vitamin d) which include:
- cardiovascular adverse effects
- phosphate calcifications
- cardiac contraction/conduction
- malabsorption
- renal dysfunction
- sarcoidosis
- arrhythmia
- electrolyte imbalance
- hypercalcemia
- renal dysfunction
- hepatobiliary dysfunction
Report options
More about Caltrate Gummy Bites (calcium / vitamin d)
- Caltrate Gummy Bites consumer information
- Compare alternatives
- Side effects
- Dosage information
- Drug class: vitamin and mineral combinations
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
